Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity

Area of Science:

• Immunology
• Neuroscience

Background:

• Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder initiated by T cell autoantigen recognition.
• Monocyte/macrophage lineage cells release inflammatory cytokines like interleukin-1 beta and tumor necrosis factor alpha, influencing immune regulation in MS.
• Understanding monocyte inflammatory gene expression is crucial for MS pathogenesis.

Purpose of the Study:

• To investigate spontaneous secretion of inflammatory mediators by monocytes in active MS, stable MS, and healthy controls.
• To compare the levels of interleukin-1 beta, tumor necrosis factor alpha, and prostaglandin E2 in different MS disease states.

Main Methods:

• Isolated monocytes from active MS (n=9), stable MS (n=9), and age-matched healthy controls (n=9).
• Purified monocytes using density gradient centrifugation and adherence.
• Measured spontaneous secretion of interleukin-1 beta, tumor necrosis factor alpha, and prostaglandin E2.
• Assessed monocyte response to lipopolysaccharide stimulation.

Main Results:

• Monocytes from active MS patients secreted less tumor necrosis factor alpha and prostaglandin E2 compared to stable MS patients.
• Interleukin-1 beta levels were below assay sensitivity in all groups.
• Lipopolysaccharide stimulation increased cytokine and prostaglandin E2 levels, with greater increase in stable MS patients, indicating differential sensitivity.

Conclusions:

• Monocyte inflammatory gene expression differs between active and stable MS patients.
• Reduced spontaneous secretion of TNF-alpha and PGE2 in active MS suggests a distinct inflammatory profile.
• Differential sensitivity to stimuli may play a role in the varying inflammatory responses observed in MS.